Axonics, Inc. Competitor Insights

Axonics, Inc. is a medical technology company focused on developing and commercializing innovative solutions for bladder and bowel dysfunction. Their primary offering is Axonics Therapy, a sacral neuromodulation (SNM) system designed to treat overactive bladder, bowel incontinence, and urinary retention. Axonics utilizes a direct-to-consumer marketing approach, coupled with outreach to healthcare professionals, to raise awareness and drive adoption of their therapy. They gather leads through online quizzes and contact forms, offering potential patients the opportunity to assess their eligibility for Axonics Therapy. The company is committed to protecting patient privacy, adheres to data protection regulations, and provides detailed information about safety and potential risks associated with their products. Axonics operates in the United States, Canada, Europe and Australia, with a global presence and a focus on expanding access to their therapy for patients worldwide.